We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > MATRIX

News List

GentiBio raises $157m to develop Treg therapies for autoimmune diseases pharmaceutical-technology
August 13, 2021
GentiBio has raised $157m in a Series A funding round led by Matrix Capital Management to progress its new pipeline of engineered regulatory T cell (Treg) treatments in immunology.
Triastek Closes US$ 50 Million Series B Financing, Co-led by Matrix Partners China and CPE prnasia
June 25, 2021
Triastek, Inc., a global leader in 3D printed pharmaceuticals, has completed its Series B financing, raising US$ 50 million (RMB 330 million).
Matrix Collaborates with AstraZeneca on Trial for COVID-19 Long-Acting Antibody Combination americanpharmaceuticalreview
February 09, 2021
Matrix Medical Network® announced a collaboration with AstraZeneca to accelerate a clinical trial in the US for AZD7442, AstraZeneca's long-acting monoclonal antibody (LAAB) combination for the potential prevention of COVID-19.
Cellect, denovoMATRIX start stem cell research project fiercebiotech
July 09, 2018
Cellect Biotechnology and a group at Technische Universität Dresden (TU Dresden) have teamed upto explore the combination of their stem cell technologies.